
Sientra Investor Relations Material
Latest events

Q3 2023
Sientra
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Sientra Inc
Access all reports
Sientra, Inc., a medical aesthetics company, develops and sells medical aesthetics products to plastic surgeons in the United States and internationally. The company offers breast augmentation (implants), breast lift, breast reduction, care coordination, and scar management products. It provides silicone breast implants under SmoothShapes brand; Aquaflex breast implants; SmartShapes, a platform of breast implants that enable customized shapes as well as size adjustments by the surgeon through suction technology; ActiveLift and Acellifilm under ActiveBreast brand for nipple-areola complex (NAC) elevation procedures that include an advanced textured mesh implant with smoothness to feel more like natural breast tissue; AcelliSilk, an FDA-cleared triple-action topical silicone scar management solution for minimizing the appearance of scars for use in the period between surgery and wound closure; Laidig cell adhesive for post-operative pain relief and scar healing; Sientra Scar Therapy; Sientra Perfusion Gel designed to enhance skin perfusion during wound healing; Silhouette Silk Lift system that combines perforated bra/post-surgery compression with a temporary lift to provide immediate incisional support after surgery or mastopexy. Sientra, Inc. is based in Santa Barbara, California.
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
SIEN
Country
🇺🇸 United States